Rational discovery of peptide inhibitors targeting Keap1: a focus on neurodegenerative diseases
Nandhini Senthilkumar, Shanthi Veerappapillai · 2026
Read Rational discovery of peptide inhibitors targeting Keap1: a focus on neurodegenerative diseases by Nandhini Senthilkumar, Shanthi Veerappapillai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619834.txt.
Description
Nandhini Senthilkumar and Shanthi Veerappapillai published a drug design study in twenty twenty-six that works by computer alone. Their target is a cell switch: free a protective factor, Nrf2, from its keeper, Keap1, and cells boost their shields against damage. That boost is sought in diseases of the aging brain.
The pair built a library of over thirteen thousand short protein chains based on the natural key. They screened the set for safety, for the power to cross into the brain, and for strength of fit. Eleven chains passed. Long computer runs of the best pairs showed a firm, stable grip. The authors offer the top chains as leads for lab tests, with all the checks done in silico first to save time and cost.
Catalog record
| CREATOR | Nandhini Senthilkumar, Shanthi Veerappapillai |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |